Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H. Nygaard M, et al. Among authors: andersen ns. Bone Marrow Transplant. 2019 Jan;54(1):35-43. doi: 10.1038/s41409-018-0206-5. Epub 2018 May 8. Bone Marrow Transplant. 2019. PMID: 29740177 Clinical Trial.
Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
Mortensen BK, Petersen SL, Kornblit B, Andersen PK, Braendstrup P, Andersen NS, Sengeløv H, Vindeløv L. Mortensen BK, et al. Among authors: andersen ns, andersen pk. Eur J Haematol. 2012 Aug;89(2):151-9. doi: 10.1111/j.1600-0609.2012.01801.x. Epub 2012 Jun 25. Eur J Haematol. 2012. PMID: 22574687
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire.
Xavier E, Cornillon J, Ruggeri A, Chevallier P, Cornelissen JJ, Andersen NS, Maillard N, Nguyen S, Blaise D, Deconinck E, Veelken H, Milpied N, Van Gelder M, Peffault de Latour R, Gluckman E, Kröger N, Schetelig J, Rocha V. Xavier E, et al. Among authors: andersen ns. Biol Blood Marrow Transplant. 2015 Aug;21(8):1515-23. doi: 10.1016/j.bbmt.2015.04.026. Epub 2015 May 7. Biol Blood Marrow Transplant. 2015. PMID: 25958294 Free article.
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.
Schetelig J, de Wreede LC, van Gelder M, Andersen NS, Moreno C, Vitek A, Karas M, Michallet M, Machaczka M, Gramatzki M, Beelen D, Finke J, Delgado J, Volin L, Passweg J, Dreger P, Henseler A, van Biezen A, Bornhäuser M, Schönland SO, Kröger N. Schetelig J, et al. Among authors: andersen ns. Bone Marrow Transplant. 2017 Apr;52(4):552-560. doi: 10.1038/bmt.2016.329. Epub 2017 Jan 23. Bone Marrow Transplant. 2017. PMID: 28112746
C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
Minculescu L, Kornblit BT, Friis LS, Schiødt I, Petersen SL, Andersen NS, Sengeloev H. Minculescu L, et al. Among authors: andersen ns. Biol Blood Marrow Transplant. 2018 Mar;24(3):600-607. doi: 10.1016/j.bbmt.2017.10.025. Epub 2017 Oct 23. Biol Blood Marrow Transplant. 2018. PMID: 29074374 Free article. Clinical Trial.
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.
Dreger P, Michallet M, Bosman P, Dietrich S, Sobh M, Boumendil A, Nagler A, Scheid C, Cornelissen J, Niederwieser D, Müller L, Vandenberghe E, Scortechini I, Schoemans H, Andersen NS, Finke J, Russo D, Ljungman P, Passweg J, van Gelder M, Durakovic N, Labussiere-Wallet H, Berg T, Wulf G, Bethge W, Bunjes D, Stilgenbauer S, Canepari ME, Schaap M, Fox CP, Kröger N, Montoto S, Schetelig J. Dreger P, et al. Among authors: andersen ns. Bone Marrow Transplant. 2019 Jan;54(1):44-52. doi: 10.1038/s41409-018-0207-4. Epub 2018 May 4. Bone Marrow Transplant. 2019. PMID: 29728701 Clinical Trial.
Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches.
Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H. Nygaard M, et al. Among authors: andersen ns. Bone Marrow Transplant. 2019 Jan;54(1):150-154. doi: 10.1038/s41409-018-0262-x. Epub 2018 Jun 15. Bone Marrow Transplant. 2019. PMID: 29907805 Clinical Trial. No abstract available.
91 results